Carregant...

NF-κB Inhibition by Bortezomib Permits Interferon-γ-Activated RIP1 Kinase-Dependent Necrosis in Renal Cell Carcinoma

Advanced renal cell carcinoma (RCC) is an invariably fatal cancer. Currently, small-molecule inhibitors that target cell-growth, angiogenesis, or nutrient-sensing pathways represent the primary pharmacological interventions for this disease, but these inhibitors only delay tumor progression and are...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Thapa, Roshan J., Chen, Peirong, Cheung, Mitchell, Nogusa, Shoko, Pei, Jianming, Peri, Suraj, Testa, Joseph R., Balachandran, Siddharth
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3746800/
https://ncbi.nlm.nih.gov/pubmed/23657944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-1010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!